Research Progress in the Prevention and Treatment of Osteoporosis Using Chinese Medicinal Herb Eucommia ulmoides Oliver
DOI:
https://doi.org/10.53469/jcmp.2024.06(06).03Keywords:
Eucommia ulmoides, Osteoporosis, Eucommia extract, Total lignans of eucommia, Iridoid glycosides of eucommia, Flavonoids of eucommia, Eucommia, RescriptionsAbstract
Osteoporosis (OP), a common bone metabolic disease in clinical practice, imposes a heavy burden on families and society due to the fragility fractures it causes. With the advent of an aging society, the prevention and treatment of OP has become a significant challenge worldwide. Currently, the treatment of OP primarily focuses on promoting bone formation and reducing bone loss. While these therapeutic approaches have clear goals and notable effects, they are still accompanied by certain toxic side effects. With the development of traditional Chinese medicine (TCM) in OP prevention and treatment, the therapeutic targets and mechanisms of action of TCM and its active ingredients are gradually gaining recognition. The traditional Chinese medicine Eucommia ulmoides (Du Zhong) and its prescriptions have demonstrated remarkable efficacy in clinically preventing and treating OP. In recent years, research on the anti-OP effects of Eucommia ulmoides and its active ingredients has become a hot topic, and their effectiveness has been confirmed. This article systematically reviews the research on Eucommia ulmoides extract, total lignans, iridoid glycosides, flavonoids, and their prescriptions, aiming to provide new perspectives for TCM in the field of OP prevention and treatment.
References
Working Group for "Chinese Guidelines for the Diagnosis and Treatment of Osteoporosis in the Elderly (2023)", Osteoporosis Branch of the Chinese Geriatrics Society and Chinese Geriatric Medicine Society, Osteoporosis Branch of the China International Medical Exchange and Promotion Association, Osteoporosis Prevention and Rehabilitation Committee of the Chinese Association of Rehabilitation Medicine, Comprehensive Demonstration Research Group for Prevention and Control of Common Clinical Problems in the Elderly, Chinese Guidelines for the Diagnosis and Treatment of Osteoporosis in the Elderly (2023) [J]. Chinese Journal of Bone and Joint Surgery, 2023, (10): 865-885.
Chinese Pharmacopoeia [M]. Volume 1. 2020: 172.
Hu Yang, Li Xianzhi, Liu Yang, et al. Research Progress on Chemical Constituents, Pharmacological Effects, and Applications of Eucommia ulmoides [J]. Asia-Pacific Traditional Medicine, 2022, (02): 234-239.
Qi S, Zheng H, Chen C, Jiang H. Du-Zhong (Eucommia ulmoides Oliv.) Cortex Extract Alleviates Lead Acetate-Induced Bone Loss in Rats. Biol Trace Elem Res (BTER). 2019 Jan;187(1):172-180.
Lin J, Fan YJ, Mehl C, et al. Eucommia ulmoides Oliv. antagonizes H2O2-induced rat osteoblastic MC3T3-E1 apoptosis by inhibiting expressions of caspases 3, 6, 7, and 9. J Zhejiang Univ Sci B (JZUSB). 2011 Jan;12(1):47-54.
Chen Mengyu, Du Jie, Xiao Cheng. Eucommia ulmoides Leaf Extract Alleviates Neuronal Injury Caused by Ischemia/Reperfusion by Upregulating miR-140-5p [J]. Chinese Journal of Gerontology, 2023, (07): 1735-1739.
Liu Yuehui, Zhang Bo, Li Wei, et al. Effects of Ethanol Extract of Eucommia ulmoides Leaves on Biochemical Markers of Bone Metabolism, Bone Density, IL-6, and TNF-α in Ovariectomized Rats with Osteoporosis [J]. Chinese Journal of Traditional Chinese Medicine, 2018, (03): 445-448.
Tong Yan, Li Na, Li Rui, et al. Effects of Salt-Processed Eucommia ulmoides on Bone Density and Serum IGF-I in Ovariectomized Rats [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2013, (17): 255-257.
Zhang Min, Liang Fengni, Sun Yanwen, et al. Research Progress on Chemical Constituents, Pharmacological Effects, and Clinical Applications of Eucommia ulmoides [J]. Chinese Herbal Medicines, 2023, (14): 4740-4761.
Lan Bo, Liu Ting, Xie Yumin, et al. Effects of Two Flavonoid Compounds from Eucommia ulmoides on Osteoprotegerin/Receptor Activator of Nuclear Factor-κB Ligand (OPG/RANKL) and Osteogenic- Related Transcription Factors in Osteoblasts [J]. Chinese Journal of Experimental Traditional Medical Formulae, 2014, (22): 180-184.
Li Sanhua, He Zhiquan, Chen Quanli, et al. Effects of Total Flavonoids from Eucommia ulmoides on Osteoblast Proliferation and Type I Collagen Protein Expression [J]. Northwest Pharmaceutical Journal, 2011, (04): 272-274.
Yuan Zhen, Min Jun, Wang Kai, et al. Comparative Study of Three Drug Components of Eucommia ulmoides Flavonoids in the Treatment of Osteoporosis in Rats [J]. Chinese Journal of Osteoporosis, 2018, (02): 244-248.
Zhang R, Pan YL, Hu SJ, et al. Effects of total lignans from Eucommia ulmoides barks prevent bone loss in vivo and in vitro. J Ethnopharmacol (JE). 2014 Aug 8; 155(1): 104-12.
Weng Zebin, Yan Cuiping, Gao Qianqian, et al. Effects of Drug-Containing Serum from Different Processed Products of Eucommia ulmoides and Its Iridoid Glycosides on the Proliferation and Differentiation of Osteoblasts in Postmenopausal Women [J]. Shi Zhen Medical and Pharmaceutical Journal, 2015, (11): 2636-2638.
Gu F, Jiang J, Wang S, Feng T, et al. An experimental research into the potential therapeutic effects of Anti-Osteoporosis Decoction and Yougui Pill on ovariectomy-induced osteoporosis. Am J Transl Res (AJTR). 2019 Sep 15; 11(9): 6032-6039.
Li Linghan, Mai Peigen, Chen Baohong. Effects of Yougui Pill on Bone Mineral Density, Bone Metabolism, and Incidence of Fragility Fractures in Patients with Primary Osteoporosis [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2017, (19): 2088-2090.
Cao Junqing, Zheng Jiannan, Zhang Lin. Clinical Study on the Treatment of Kidney Yang Deficiency Syndrome of Postmenopausal Osteoporosis with Yougui Pill Combined with Alendronate Sodium Orally [J]. Chinese Journal of Orthopedics and Traumatology, 2018, (05): 20-23.
Hao J, Bei J, Li Z, et al. Qing'e Pill Inhibits Osteoblast Ferroptosis via ATM Serine/Threonine Kinase (ATM) and the PI3K/AKT Pathway in Primary Osteoporosis. Front Pharmacol (FP). 2022 Jul 5; 13:902102.
Lu J, Hu D, Ma C, et al. Modified Qing'e Pills exerts anti-osteoporosis effects and prevents bone loss by enhancing type H blood vessel formation. Front Endocrinol (FE). 2022 Sep 6; 13:998971.
Xie H, Hua Z, Guo M, et al. Gut microbiota and metabonomics used to explore the mechanism of Qing'e Pills in alleviating osteoporosis. Pharm Biol (PB). 2022 Dec; 60(1):785-800.
Yu Hai, Xu Xiaojuan, Shen Lin, et al. Effects of Qing'e Pill on Bone Mineral Density, Bone Turnover Markers, and Osteopontin in Postmenopausal Osteoporosis Patients [J]. Chinese Journal of Orthopedics and Traumatology, 2016, (01): 21-23.
He Xiaolei, Ren Cunxia, Shi Jun. Analysis of the Mechanism of Erwei Duzhong Tang in the Treatment of Postmenopausal Osteoporosis Based on Network Pharmacology and Molecular Docking Technology [J]. Modern Medications & Clinic, 2022, (12): 2707-2713.
Liu Jin, Li Guohua, Hao Jingtao. Effects of Mongolian Medicine Erwei Duzhong Tang on Serum Interleukin-4 and Interleukin-6 in Ovariectomized Rats [J]. Chinese Journal of Ethnomedicine and Ethnopharmacology, 2021, (02): 34-36.
Zhao Jun, Xie Jinghua. Clinical Study on the Treatment of PMOP Bone Pain with Mongolian Medicine Tabusen-2 Capsules [J]. Chinese Journal of Ethnomedicine and Ethnopharmacology, 2019, (07): 1-3.
Xing Wei, Chen Yanyan, Wang Shuren, et al. Study on the Mechanism of Duzhong Jiangu Recipe in Treating Osteoporosis in Rats [J]. Journal of Guangdong Pharmaceutical University, 2020, (02): 254-258.
Xing Wei, Chen Yanyan, Wang Shuren, et al. Study on the Mechanism of Duzhong Jiangu Recipe in Treating Osteoporosis Based on the PI3K/AKT/GSK-3β Signaling Pathway [J]. Journal of Guangdong Pharmaceutical University, 2021, (01): 67-71+90.
Liu Wei, Wang Wenzhi, Li Zhiyong, et al. Exploring the Therapeutic Effect of Duzhong Jiangu Recipe on Osteoporosis in Rats Based on the Wnt 5a/β-catenin Signaling Pathway [J]. Liaoning Journal of Traditional Chinese Medicine, 2024, (01): 201-205.
Yue Zhijun, Jiang Ziwei, Li Zige, et al. Exploring the Molecular Mechanism of Bushen Huoxue Tang in Treating Osteoporosis Based on Network Pharmacology and Molecular Docking [J]. Chinese Journal of Osteoporosis, 2021, (04): 542-548+584.
Xu Jianguo, Liang Na, Chen Zetao. Study on the Effect of Bushen Jianpi Huoxue Tang on Bone Metabolism in Type 2 Diabetic Osteoporosis Rats [J]. Shanxi Journal of Traditional Chinese Medicine, 2015, (05): 48-49+58.
Jin Qiao, Niu Zhijun. Observation on the Therapeutic Effect of Bushen Huoxue Tang Combined with Caltrate in the Treatment of Postmenopausal Primary Osteoporosis [J]. Sichuan Journal of Traditional Chinese Medicine, 2015, (06): 128-130.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hongze Wang, Geng Liu, Guoyang Bai, Qiang Zan
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
